Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2006
-
By Jason Derry — As reported by the San Diego Union Tribune, the Scripps Research Institute and Pfizer Inc. have agreed on a 5 year, $100 million partnership. The arrangement provides Pfizer the option of licensing up to 47% of the discoveries made at Scripps over the next 5 years, while Scripps receives…
-
By Jason Derry — North Carolina based INC Research® has announced that Dr. Tetsushi Inada will be its senior liaison officer to Japan. The appointment is part of INC Research’s initiative to expand its clinical expertise services and increase its presence in Asian countries. INC Research® is a contract research organization that specializes…
-
By Jason Derry — Dyax Corp. and the Australian national scientific research agency, CSIRO, have announced a collaborative partnership to discover and develop antibodies for treating cancer. Dyax will provide the antibody libraries and screen for potential clinical leads, while CSIRO will test the leads and work on developing the leads into clinically…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma patent cases. A few interesting cases will be selected for periodic monitoring, providing our readers with an opportunity to follow the progress of these cases. Stratagene California v. Bio-Rad Laboratories Inc. et al.3:06-cv-02553; filed…
-
By Christopher P. Singer — In a November 27, 2006 press release Cytogen announced that U.S. Patent No. 7,135,457 issued for oral drug delivery agents that are random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors. These agents aid in the transport of active agents from the lumen of mammalian GIT…
-
By Mark Chael — On November 22, 2006, the Board of Patent Appeals and Interferences (BPAI) at the U.S. Patent and Trademark Office decided a patent interference in favor of Prof. J. Gregor Sutcliffe and colleagues at the Scripps Research Institute related to hypocretins. Hypocretins are a recently discovered family of neuropeptide hormones…
-
By Jason Derry — The Philadelphia Inquirer reported today that Delaware has instituted a new agency to receive donated patents with the goal of inspiring economic growth within the State. The agency hopes to generate Delaware-based companies through licensing of its available patents. The agency currently has over 250 patents from DuPont Co.…
-
By Donald Zuhn — In an appeal from a District Court judgment of infringement of U.S. Patent Nos. 5,714,520; 5,731,355; and 5,731,356, the Federal Circuit reversed the District Court's claim construction and finding of literal infringement, and affirmed the District Court's finding of infringement under the doctrine of equivalents. The patents at issue…
-
By Christopher P. Singer — In a November 22, 2006 press release, Introgen Therapeutics, Inc. (INGN) announced that it has been awarded U.S. Patent No. 7,125,706, titled "An Improved Method for the Production and Purification of Adenoviral Vectors." This patent represents the third issued U.S. patent in Introgen’s adenoviral vector intellectual property portfolio. …
-
By Christopher P. Singer — Pfizer and Teva on November 21, 2006 announced that the companies reached an agreement that resolves litigation surrounding the drugs idarubicin and azithromycin, as well as issues relating to epirubicin. The resolution includes full releases between the parties and directs a payment as large as $70 million from…
Patent Docs 